QIAGEN launches Oncology Molecular Profiling Services in Europe
(WorldNews Netherlands)

Redwood City, California, and Hilden, Germany, January 15, 2020- QIAGEN today announced the launch of QCI Precision Insightsin Europe, with the inclusion of the European Society for Medical Oncology (ESMO) guidelinesand European Medicines Agency (EMA)approved oncology drugs catalogue. QCI Precision Insights is a clinical interpretation service provided by a team of molecular biologists and oncologists who translate molecular data specific to each patient into state-of-the-art clinical insights and therapeutic options. Capable of rapidly interpreting any size panel on any testing platform, QCI Precision Insights now enables molecular pathologists and oncologists in Europe to confidently match...